Glass House Brands Subordinate Voting Shares (GLAS) vs MediWound (MDWD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
MediWound (MDWD) has outperformed Glass House Brands Subordinate Voting Shares (GLAS) over the past year, losing 29.5% versus a loss of 44.9%. Over five years, GLAS leads with a -11.7% price change compared with -48.0% for MDWD. Glass House Brands Subordinate Voting Shares is the larger company by market cap ($415.6 million vs $160.3 million), about 2.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GLAS | MDWD |
|---|---|---|
| Share price | $4.41 | $12.42 |
| Market cap | $415.61M | $160.35M |
| 1-day change | -14.04% | -3.35% |
| YTD return | -50.17% | -32.72% |
| 1-year return | -44.88% | -29.53% |
| 5-year return | -11.71% | -47.97% |
| Forward P/E | 19.60 | — |
| EPS (TTM) | $-0.74 | $-2.17 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.93 | $20.03 |
| 52-week low | $4.20 | $12.42 |
| Distance from 52-week high | -68.34% | -37.99% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +262.81% | +146.94% |
| Average volume | 805.40K | 84.01K |
| Shares outstanding | 88.00M | 12.91M |
| Employees | 357 | 121 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Glass House Brands Subordinate Voting Shares is about 2.6 times larger than MediWound by market value ($415.61M vs $160.35M).
- MDWD has outperformed GLAS by 15.3 percentage points over the past year.
About Glass House Brands Subordinate Voting Shares
GLAS stock →Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.
Health Care · Medicinal Chemicals and Botanical Products · 357 employees
About MediWound
MDWD stock →MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.
Health Care · Medicinal Chemicals and Botanical Products · 121 employees
GLAS vs MDWD FAQ
Which is bigger, Glass House Brands Subordinate Voting Shares or MediWound?
Glass House Brands Subordinate Voting Shares (GLAS) is larger, with a market capitalization of $415.61M compared with $160.35M for MediWound (MDWD).
Which stock has performed better over the past year, GLAS or MDWD?
MDWD returned -29.53% over the past 12 months, compared with -44.88% for GLAS (price return, excluding dividends). Past performance does not predict future results.
Are Glass House Brands Subordinate Voting Shares and MediWound in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.